Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451471
Status:
COMPLETED
Last Update Posted:
2024-06-11
First Post:
2024-06-04
Brief Title:
Galectin-3 as a Marker of Subclinical Inflammation in FMF
Sponsor:
Turkish League Against Rheumatism
Organization:
Turkish League Against Rheumatism
Study Overview
Official Title:
Assessment of Serum Galectin-3 Level as an Indicator of Subclinical Inflammation in Patients With Familial Mediterranean Fever
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to learn about the relationship between serum Galectin-3 levels and subclinical inflammation in patients with Familial Mediterranean Fever FMF The main questions it aims to answer are
Are serum Galectin-3 levels higher in FMF patients compared to healthy controls
Is there a positive correlation between serum Galectin-3 levels and Serum Amyloid A SAA protein levels in FMF patients
Participants will
Provide blood samples to measure serum Galectin-3 and SAA levels
Complete a sociodemographic and clinical data form
Fill out the FMF Quality of Life QoL scale
Researchers will compare FMF patients and healthy controls to see if there are significant differences in serum Galectin-3 levels and to determine the correlation between Galectin-3 and SAA protein levels in FMF patients
Are serum Galectin-3 levels higher in FMF patients compared to healthy controls
Is there a positive correlation between serum Galectin-3 levels and Serum Amyloid A SAA protein levels in FMF patients
Participants will
Provide blood samples to measure serum Galectin-3 and SAA levels
Complete a sociodemographic and clinical data form
Fill out the FMF Quality of Life QoL scale
Researchers will compare FMF patients and healthy controls to see if there are significant differences in serum Galectin-3 levels and to determine the correlation between Galectin-3 and SAA protein levels in FMF patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None